Searle & Co’s Takeda Pharmaceutical TAK Stock Holding History

Searle & Co’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-31,697	Closed	-$454K	–	156
2022 Q1	$454K	Sell	31,697 -70	-0.2%	-$1.03K	0.17%	108
2021 Q4	$433K	Hold	31,767	–	–	0.16%	109
2021 Q3	$520K	Hold	31,767	–	–	0.21%	88
2021 Q2	$535K	Sell	31,767 -1,641	-5%	-$27.9K	0.22%	90
2021 Q1	$610K	Sell	33,408 -3,523	-10%	-$63.4K	0.27%	80
2020 Q4	$672K	Buy	36,931 +70	+0.2%	+$1.23K	0.32%	75
2020 Q3	$658K	Hold	36,861	–	–	0.36%	69
2020 Q2	$661K	Hold	36,861	–	–	0.38%	71
2020 Q1	$560K	Hold	36,861	–	–	0.4%	68
2019 Q4	$727K	Sell	36,861 -168	-0.5%	-$3.21K	0.4%	68
2019 Q3	$637K	Sell	37,029 -167	-0.4%	-$2.89K	0.38%	70
2019 Q2	$658K	Hold	37,196	–	–	0.4%	66
2019 Q1	$758K	Buy	+37,196	New	+$748K	0.47%	60

Other funds holding TAK

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return